SEC Filings | Constellation Pharmaceuticals

SEC Filings

Filing date	Form	Description	Filing Group	View
Aug 05, 2020	10-Q	Quarterly report which provides a continuing view of a company's financial position	Quarterly Filings	0001564590-20-036390.pdf 0001564590-20-036390.rtf 0001564590-20-036390.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
Jul 08, 2020	3	Initial filing by director officer or owner of more than ten percent.	3,4,5	0001562180-20-005076.pdf 0001562180-20-005076.rtf 0001562180-20-005076.xls View HTML
Jul 08, 2020	4	Statement of changes in beneficial ownership of securities	3,4,5	0001562180-20-005078.pdf 0001562180-20-005078.rtf 0001562180-20-005078.xls View HTML
Jun 24, 2020	SC 13G/A	An amendment to the SC 13G filing	Other	0001193125-20-177668.pdf 0001193125-20-177668.rtf 0001193125-20-177668.xls View HTML
Jun 17, 2020	424B5	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	Registration Statements	0001193125-20-171466.pdf 0001193125-20-171466.rtf 0001193125-20-171466.xls View HTML
Jun 17, 2020	8-K	Report of unscheduled material events or corporate event	Current Reports	0001193125-20-171476.pdf 0001193125-20-171476.rtf 0001193125-20-171476.xls View HTML
Jun 15, 2020	8-K	Report of unscheduled material events or corporate event	Current Reports	0001193125-20-169325.pdf 0001193125-20-169325.rtf 0001193125-20-169325.xls View HTML
Jun 15, 2020	424B5	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	Registration Statements	0001193125-20-169318.pdf 0001193125-20-169318.rtf 0001193125-20-169318.xls View HTML
Jun 10, 2020	4	Statement of changes in beneficial ownership of securities	3,4,5	0001562180-20-004418.pdf 0001562180-20-004418.rtf 0001562180-20-004418.xls View HTML
Jun 08, 2020	8-K	Report of unscheduled material events or corporate event	Current Reports	0001193125-20-162823.pdf 0001193125-20-162823.rtf 0001193125-20-162823.xls View HTML

Data provided by Kaleidoscope.